“Wow, we need to be on NYSE or NASDAQ to be reco
Post# of 148152
(Total Views: 488)
Posted On: 04/15/2020 5:23:18 PM
“Wow, we need to be on NYSE or NASDAQ to be recognized, at least I think.”
Myself and others have said many times that CYDY’s status as an OTC stock does not bode well for its reputation, even after stunning HIV, cancer and now COVID results.
Investors and even non-investors here the term “pink sheets” or penny stock and automatically get turned away, even though the company is valued in the hundreds of millions to billions.
I personally believe uplisting would bring many large institutional investors and much more attention, but I understand the PPS requirement and cash issue that CYDY does not meet right now. The SP will be well over $4 if leronlimab is approved for COVID, but until then, we play the underdog game.
Myself and others have said many times that CYDY’s status as an OTC stock does not bode well for its reputation, even after stunning HIV, cancer and now COVID results.
Investors and even non-investors here the term “pink sheets” or penny stock and automatically get turned away, even though the company is valued in the hundreds of millions to billions.
I personally believe uplisting would bring many large institutional investors and much more attention, but I understand the PPS requirement and cash issue that CYDY does not meet right now. The SP will be well over $4 if leronlimab is approved for COVID, but until then, we play the underdog game.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼